Core Insights - American Express reported revenue of $18.43 billion for the quarter ended September 2025, reflecting a year-over-year increase of 10.8% [1] - The earnings per share (EPS) for the quarter was $4.14, up from $3.49 in the same quarter last year, exceeding the consensus estimate of $3.96 by 4.55% [1] Financial Performance - The reported revenue surpassed the Zacks Consensus Estimate of $17.99 billion, resulting in a surprise of +2.42% [1] - Total Card Member loans amounted to $144.81 billion, slightly below the average estimate of $145.06 billion [4] - Risk-Based Capital Ratios (Basel III) for Common Equity Tier 1/Risk Weighted Assets were reported at 10.5%, compared to the estimated 10.8% [4] - Total non-interest revenues reached $13.94 billion, exceeding the average estimate of $13.71 billion [4] Loan Metrics - Commercial Services - Total Card Member loans were reported at $30.69 billion, below the average estimate of $30.84 billion [4] - International Card Services - Average loans for consumer and small business were $19.65 billion, above the estimated $19.43 billion [4] - U.S. Consumer Services - Total loans were reported at $94.14 billion, slightly below the average estimate of $94.23 billion [4] Stock Performance - American Express shares have returned -5.4% over the past month, while the Zacks S&P 500 composite increased by +0.7% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Core Viewpoint - Stryker Corporation is a leading medical technology company set to announce its fiscal third-quarter earnings for 2025, with analysts expecting a positive earnings report and growth in EPS over the coming years [1][2][3]. Financial Performance - Analysts anticipate Stryker to report a profit of $3.14 per share for Q3 2025, reflecting a 9.4% increase from $2.87 per share in the same quarter last year [2]. - For the full fiscal year 2025, EPS is expected to be $13.50, a 10.8% increase from $12.19 in fiscal 2024, with further growth projected to $14.95 in fiscal 2026, representing a year-over-year rise of 10.7% [3]. Stock Performance - Stryker's stock has underperformed compared to the S&P 500 Index, which gained 13.5% over the past 52 weeks, while Stryker shares only increased by 2.2% during the same period [4]. - The stock also lagged behind the Health Care Select Sector SPDR Fund, which experienced a 7.2% decline [4]. Competitive Landscape - The company's underperformance is attributed to increased competition from Zimmer Biomet, Johnson & Johnson, and Medtronic, particularly in the robotic orthopedics segment, along with macroeconomic pressures such as inflation and wage pressures affecting margins [5]. Analyst Sentiment - The consensus among analysts is moderately bullish, with a "Moderate Buy" rating overall. Out of 28 analysts, 18 recommend a "Strong Buy," 2 suggest a "Moderate Buy," and 8 advise a "Hold" [7]. - The average analyst price target for Stryker is $434.48, indicating a potential upside of 17.7% from current levels [7].

Core Insights - EQT Corporation is a major player in the natural gas sector, with a market capitalization of $33.2 billion, involved in production, gathering, and transportation of natural gas and liquids [1] - The company is expected to report a significant profit increase in its upcoming fiscal Q3 earnings announcement, with analysts projecting earnings of $0.47 per share, a 291.7% rise from the previous year [2] Financial Performance - For the current fiscal year ending in December, EQT is anticipated to report earnings of $2.86 per share, reflecting a 77.6% increase from $1.61 per share in fiscal 2024 [3] - The company's quarterly revenue for Q2 was reported at $2.6 billion, marking a 168.5% increase year-over-year, driven by a 91.2% growth in natural gas, natural gas liquids, and oil sales [5] Stock Performance - EQT's stock has increased by 45.2% over the past 52 weeks, significantly outperforming the S&P 500 Index's 13.5% gain and the Energy Select Sector SPDR Fund's 5.5% decline [4] - Wall Street analysts have a positive outlook on EQT's stock, with a "Strong Buy" rating from 19 out of 26 analysts, and a mean price target of $64, indicating a potential upside of 20.2% [6]

Company Overview - Leidos Holdings, Inc. (LDOS) is a Virginia-based technology company specializing in defense, aviation, information technology, and biomedical research with a market cap of $23.9 billion and approximately 47,000 employees [1] - The company operates across four primary divisions: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems [1] Earnings Expectations - Analysts expect LDOS to report a profit of $2.62 per share on a diluted basis for the fiscal third quarter of 2025, which represents a decline of 10.6% from $2.93 per share in the same quarter last year [2] - For the full fiscal year, analysts anticipate an EPS of $11.41, reflecting an increase of 11.8% from $10.21 in fiscal 2024 [3] Stock Performance - Over the past 52 weeks, LDOS stock has increased by 9.7%, which is lower than the S&P 500 Index's 13.5% gains and the Technology Select Sector SPDR Fund's 24% gains during the same period [4] - Following the release of strong Q2 results on August 5, Leidos Holdings' shares surged by 7.5%, with revenue rising 2.9% year over year to $4.3 billion, exceeding expectations [5] Analyst Ratings - The consensus opinion on LDOS stock is reasonably bullish, with a "Moderate Buy" rating overall; out of 16 analysts, ten recommend a "Strong Buy," one suggests "Moderate Buy," and five give a "Hold" [6] - The average analyst price target for LDOS is $196.28, indicating a potential upside of 6.4% from current levels [6]

Core Insights - American Express Company is set to release its third-quarter earnings results on October 17, with analysts expecting earnings of $4.00 per share, an increase from $3.49 per share in the same period last year [1] - The projected quarterly revenue is $18.05 billion, up from $16.64 billion a year earlier [1] Financial Performance - The company has exceeded analyst revenue estimates for three consecutive quarters and six out of the last ten quarters [2] - Shares of American Express declined by 2.3%, closing at $323.12 on Thursday [2] Analyst Ratings - UBS analyst Eriks Najarian maintained a Neutral rating and raised the price target from $330 to $340 [4] - JP Morgan analyst Richard Shane also maintained a Neutral rating, increasing the price target from $343 to $355 [4] - Evercore ISI Group analyst John Pancari maintained an In-Line rating and raised the price target from $330 to $365 [4] - Morgan Stanley analyst Betsy Graseck maintained an Equal-Weight rating, increasing the price target from $311 to $362 [4] - Wells Fargo analyst Donald Fandetti maintained an Overweight rating and raised the price target from $350 to $375 [4]

Core Insights - J.B. Hunt Transport Services, Inc. (JBHT) reported Q3 2025 earnings of $1.76 per share, exceeding the Zacks Consensus Estimate of $1.47 and reflecting an 18.1% year-over-year increase [1][11] Financial Performance - Total operating revenues reached $3.05 billion, surpassing the Zacks Consensus Estimate of $3.02 billion, but decreased by 0.5% year over year [2][11] - Operating income increased by 8% to $242.7 million, driven by structural cost removal, improved productivity, and lower transportation costs [3][11] Segmental Highlights - Intermodal division revenues were $1.52 billion, down 2% year over year, with a 1% decrease in volume and gross revenue per load [4][5] - Dedicated Contract Services segment revenues grew 2% year over year to $864 million, supported by a 3% improvement in productivity [6][7] - Integrated Capacity Solutions revenues decreased by 1% year over year to $276 million, with an 8% decline in volume but a 9% increase in revenue per load [8][9] - Truckload revenues increased by 10% year over year to $190 million, driven by a 14% increase in load volume [10][11] - Final Mile Services revenues fell 5% year over year to $206 million, attributed to softness in demand and changes in business mix [12][13] Liquidity and Share Buyback - At the end of Q3 2025, JBHT had cash and cash equivalents of $52.3 million and long-term debt of $902.2 million [14] - The company repurchased nearly 1.6 million shares for $230 million during the quarter, with approximately $107 million remaining under its share repurchase authorization [14]

Core Insights - United Airlines Holdings, Inc. (UAL) reported mixed third-quarter 2025 results, with earnings surpassing estimates but revenues falling short [1][10] - Adjusted earnings per share (EPS) for Q3 2025 was $2.78, exceeding the Zacks Consensus Estimate of $2.64, but down 16.5% year-over-year [1][10] - Operating revenues reached $15.2 billion, missing the consensus estimate of $15.3 billion, but reflecting a 2.6% year-over-year increase [2][10] Revenue Performance - Passenger revenues, which constituted 90.7% of total revenues, increased by 1.9% year-over-year to $13.8 billion [2] - Cargo revenues grew by 3.2% year-over-year to $431 million, while revenues from other sources rose by 13.2% to $979 million [2][3] - Premium cabin revenues increased by 6% year-over-year, Basic Economy revenues rose by 4%, and loyalty revenues grew by 9% [3] Capacity and Traffic - Airline traffic, measured in revenue passenger miles, grew by 6.1%, while capacity, measured in available seat miles, expanded by 7.2% [5] - The consolidated load factor decreased by 0.7 percentage points year-over-year to 83.3% [5] Cost and Expenses - Operating expenses increased by 4.2% year-over-year to $13.8 billion [7] - Consolidated unit cost per available seat mile, excluding certain expenses, decreased by 0.9% year-over-year to 12.15 cents [7] Cash Flow and Share Repurchase - UAL generated $1.21 billion in free cash flow during the September quarter [8] - The company repurchased $19 million of its shares in Q3 2025 [8] Future Outlook - For Q4 2025, UAL anticipates adjusted EPS between $3.00 and $3.50, with the Zacks Consensus Estimate at $2.67 [9][10] - The company expects Q4 2025 to achieve the highest total operating revenue for a single quarter in its history [3]

Core Insights - Marsh & McLennan Companies, Inc. (MMC) reported third-quarter 2025 adjusted earnings per share of $1.85, exceeding the Zacks Consensus Estimate by 3.4% and reflecting an 11% year-over-year increase [1][11] - Consolidated revenues reached $6.35 billion, marking an 11% year-over-year growth and a 4% increase on an underlying basis, also surpassing the consensus estimate by 0.5% [1][11] Financial Performance - Total operating expenses rose 12.9% year over year to $5.2 billion, driven by increased compensation and benefits costs, exceeding the model estimate of $5 billion [3] - Adjusted operating income improved 13% year over year to $1.44 billion, with an adjusted operating margin of 22.7%, up 30 basis points year over year [4][11] Segment Performance Risk and Insurance Services - Revenues for this segment were $3.91 billion, up 13% year over year but missed the Zacks Consensus Estimate of $4.05 billion [5] - Adjusted operating income for the segment increased 13.3% year over year to $965 million, falling short of the consensus mark by 4.4% [5] - Marsh's revenues within this segment rose 16% year over year to $3.4 billion, with U.S./Canada operations growing 3% on an underlying basis [6] Consulting - The Consulting unit's revenues grew 9% year over year to $2.47 billion, beating the Zacks Consensus Estimate by 3.9% [8] - Adjusted operating income for the Consulting segment climbed 11% year over year to $545 million, exceeding the consensus mark by 9.4% [8] Financial Position - As of September 30, 2025, cash and cash equivalents stood at $2.5 billion, up from $2.4 billion at the end of 2024 [12] - Total assets increased to $58.8 billion from $56.5 billion at the end of 2024, while long-term debt decreased to $18.3 billion from $19.4 billion [12] - Operating cash flow for the first nine months of 2025 was $3.1 billion, up from $2.3 billion a year ago [13] Capital Deployment - The company repurchased 1.9 million shares for $400 million during the third quarter [14]

Core Insights - Snap-on Inc. reported strong third-quarter 2025 results, with both top and bottom lines exceeding Zacks Consensus Estimates and showing year-over-year growth [1][11] Financial Performance - Adjusted earnings per share reached $4.71, surpassing the Zacks Consensus Estimate of $4.59 and slightly increasing from $4.70 in the same quarter last year [1][11] - Net sales amounted to $1.191 billion, reflecting a 3.8% increase from the previous year and exceeding the Zacks Consensus Estimate of $1.151 billion [2][11] - Gross profit was $605.9 million, up 3.1% year over year, while gross margin contracted by 30 basis points to 50.9% [3] - Operating earnings before financial services totaled $278.5 million, a 10.3% increase year over year, with operating earnings as a percentage of sales rising 140 basis points to 23.4% [4] - Consolidated operating earnings, including financial services, were $347.4 million, up 7.2% year over year, with operating earnings as a percentage of revenues expanding 90 basis points to 26.9% [5] Segment Performance - Sales in the Commercial & Industrial Group increased by 0.5% to $367.7 million, impacted by a slight organic sales decline [6] - The Tools Group segment saw sales rise by 1.1% to $506 million, driven by higher international activity and slight increases in the U.S. [7] - The Repair Systems & Information Group experienced a 10% year-over-year sales improvement to $464.8 million, with organic sales growth of 8.9% [8] - Financial Services revenues rose by 0.7% to $101.1 million [9] Financial Position - As of the end of Q3 2025, Snap-on had cash and cash equivalents of $1.53 billion and shareholders' equity of $5.82 billion [12] - The company anticipates capital expenditures of $100 million for 2025, with $62.5 million already spent in the first nine months [12] Future Outlook - Management expects resilience in markets and operations amid uncertainties, planning to advance core growth strategies and expand into new markets and critical industries [13]

Core Insights - Abbott Laboratories reported third-quarter sales of $11.37 billion, slightly below the consensus estimate of $11.40 billion [1] - The company narrowed its fiscal 2025 adjusted earnings guidance to a range of $5.12 to $5.18 per share, compared to the previous range of $5.10 to $5.20 per share [2] - Abbott reaffirmed its organic sales growth forecast of 7.5%-8.0%, or 6.0% to 7.0% when including COVID-19 testing sales [3] Financial Performance - Adjusted earnings for the third quarter were reported at $1.30, aligning with Wall Street estimates and within management's guidance of $1.28-$1.32 [1] - The stock price fell by 1% to $128.18 following the earnings announcement [3] Analyst Ratings and Price Targets - Wells Fargo analyst maintained an Overweight rating and raised the price target from $142 to $146 [5] - Evercore ISI Group analyst maintained an Outperform rating but reduced the price target from $144 to $142 [5] - Raymond James analyst also maintained an Outperform rating and increased the price target from $141 to $146 [5]